Parainfluenza Virus Infection
📧 Sign up to get email alerts when something new happens for Parainfluenza Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV) [Phase 2]
Phase 2 clinical trial update for PUL-042 in patients with parainfluenza virus, human metapneumovirus, or respiratory syncytial virus infect…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Study of an RSV-hMPV-PIV3 Trivalent Vaccine Candidate VXB-251 in Older Adults [Phase 1]
Phase 1 clinical trial update for VXB-251, a trivalent vaccine targeting RSV, human metapneumovirus, and parainfluenza virus type 3, studied…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults [Phase 1]
This document describes an early-phase, first-in-human safety and immunogenicity study of the vaccine candidates SCB-1022 and SCB-1033 in he…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia [NA]
Clinical trial registry entry for evaluating the LIAISON NES diagnostic assay for Influenza A/B, RSV, and COVID-19 in symptomatic patients i…